Axsome Therapeutics (AXSM) Reports Q1 Loss, Tops Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.80 per share versus the Zacks Consensus Estimate of a loss of$ 1.26. This compares to loss of $1.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 36.51%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1 per share when it actually produced a loss of $0.96, delivering a surprise of 4%.Over the last four quarters, the compa ...